{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:59:17Z","timestamp":1740124757460,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1038\/s41372-018-0159-y","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T14:24:10Z","timestamp":1530195850000},"page":"797-803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differences in prenatal aneuploidy screening among African\u2013American women with hemoglobin S variants"],"prefix":"10.1038","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7776-2941","authenticated-orcid":false,"given":"April D.","family":"Adams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendra","family":"Schaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael T.","family":"Overcash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,2]]},"reference":[{"key":"159_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00006250-200701000-00055","volume":"109","author":"ACOG Committee on Obstetrics.","year":"2007","unstructured":"ACOG Committee on Obstetrics. ACOG Practice Bulletin No. 78: hemoglobinopathies in pregnancy. Obstet Gynecol. 2007;109:229\u201337.","journal-title":"Obstet Gynecol"},{"key":"159_CR2","doi-asserted-by":"publisher","first-page":"S542","DOI":"10.1016\/j.amepre.2009.12.020","volume":"38","author":"WD Barfield","year":"2010","unstructured":"Barfield WD, Barradas DT, Manning SE, Kotelchuck M, Shapiro-Mendoza CK. Sickle cell disease and pregnancy outcomes: women of African descent. Am J Prev Med. 2010;38:S542\u20139.","journal-title":"Am J Prev Med"},{"key":"159_CR3","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1182\/blood-2014-11-607317","volume":"125","author":"E Oteng-Ntim","year":"2015","unstructured":"Oteng-Ntim E, Meeks D, Seed PT, Webster L, Howard J, Doyle P, et al. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis. Blood. 2015;125:3316\u201325.","journal-title":"Blood"},{"key":"159_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0002-9378(97)70209-6","volume":"177","author":"KD Larrabee","year":"1997","unstructured":"Larrabee KD, Monga M. Women with sickle cell trait are at increased risk for preeclampsia. Am J Obstet Gynecol. 1997;177:425\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"159_CR5","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/01.AOG.0000285995.41769.83","volume":"110","author":"AT Tita","year":"2007","unstructured":"Tita AT, Biggio JR, Chapman V, Neely C, Rouse DJ. Perinatal and maternal outcomes in women with sickle or hemoglobin C trait. Obstet Gynecol. 2007;110:1113\u20139.","journal-title":"Obstet Gynecol"},{"key":"159_CR6","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/AOG.0000000000001439","volume":"127","author":"Practice Bulletin No. 163.","year":"2016","unstructured":"Practice Bulletin No. 163. Summary: screening for fetal aneuploidy. Obstet Gynecol. 2016;127:979\u201381.","journal-title":"Obstet Gynecol"},{"key":"159_CR7","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/AOG.0b013e3181da93da","volume":"115","author":"L Dugoff","year":"2010","unstructured":"Dugoff L. Society for Maternal-Fetal Medicine. First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes. Obstet Gynecol. 2010;115:1052\u201361.","journal-title":"Obstet Gynecol"},{"key":"159_CR8","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/S1701-2163(16)32973-5","volume":"30","author":"A Gagnon","year":"2008","unstructured":"Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA, et al. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can. 2008;30:918\u201349.","journal-title":"J Obstet Gynaecol Can"},{"key":"159_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/AOG.0000000000000145","volume":"123","author":"RJ Baer","year":"2014","unstructured":"Baer RJ, Currier RJ, Norton ME, Flessel MC, Goldman S, Towner D, et al. Obstetric, perinatal, and fetal outcomes in pregnancies with false-positive integrated screening results. Obstet Gynecol. 2014;123:603\u20139.","journal-title":"Obstet Gynecol"},{"key":"159_CR10","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.humpath.2004.07.003","volume":"35","author":"P Trampont","year":"2004","unstructured":"Trampont P, Roudier M, Andrea AM, Nomal N, Mignot TM, Leborgne-Samuel Y, et al. The placental-umbilical unit in sickle cell disease pregnancy: A model for studying in vivo functional adjustments to hypoxia in humans. Hum Pathol. 2004;35:1353\u20139.","journal-title":"Hum Pathol"},{"key":"159_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/1097-0223(200101)21:1<46::AID-PD984>3.0.CO;2-C","volume":"21","author":"PA Benn","year":"2001","unstructured":"Benn PA, Ying J, Beazoglou T, Egan JF. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. Prenat Diagn. 2001;21:46\u201351.","journal-title":"Prenat Diagn"},{"key":"159_CR12","first-page":"1043","volume":"108","author":"K Spencer","year":"2001","unstructured":"Spencer K. Age related detection and false positive rates when screening for Down\u2019s syndrome in the first trimester using fetal nuchal translucency and maternal serum free beta hCG and PAPP-A. BJOG. 2001;108:1043\u20136.","journal-title":"BJOG"},{"key":"159_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/pd.4610","volume":"35","author":"AW Kneitel","year":"2015","unstructured":"Kneitel AW, Rhee-Morris L, Obadia R, Towner D. Increased false positive Down syndrome screening in women with sickle cell anemia. Prenat Diagn. 2015;35:797\u2013800.","journal-title":"Prenat Diagn"},{"key":"159_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0065-2423(06)43006-7","volume":"43","author":"GE Palomaki","year":"2007","unstructured":"Palomaki GE, Lambert-Messerlian GM, Canick JA. A summary analysis of down syndrome markers in the late first trimester. Adv Clin Chem. 2007;43:177\u2013210.","journal-title":"Adv Clin Chem"},{"key":"159_CR15","first-page":"698","volume":"50","author":"KB Rathod","year":"2007","unstructured":"Rathod KB, Jaiswal KN, Shrivastava AC, Shrikhande AV. Study of placenta in sickle cell disorders. Indian J Pathol Microbiol. 2007;50:698\u2013701.","journal-title":"Indian J Pathol Microbiol"},{"key":"159_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1053\/plac.2001.0767","volume":"23","author":"S Banerjee","year":"2002","unstructured":"Banerjee S, et al. \u201cPlacental Morphogenesis in Pregnancies with Down\u2019s Syndrome might Provide a Clue to Pre-Eclampsia\u201d. Placenta. 2002;23:172\u20134.","journal-title":"Placenta"},{"key":"159_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/plac.2000.0588","volume":"22","author":"DM Sherer","year":"2001","unstructured":"Sherer DM, Abulafia O. Angiogenesis during implantation, and placental and early embryonic development. Placenta. 2001;22:1\u201313.","journal-title":"Placenta"},{"key":"159_CR18","unstructured":"Sickle Cell Disease (SCD). Centers for Disease Control and Prevention. 2016; Available at: \n                    www.cdc.gov\/ncbddd\/sicklecell\/data.html\n                    \n                  . Accessed 31 August 2017."},{"key":"159_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bcmd.2017.06.004","volume":"70","author":"GR Serjeant","year":"2017","unstructured":"Serjeant GR, Vichinsky E. Variability of homozygous sickle cell disease: The role of alpha and beta globin chain variation and other factors. Blood Cells Mol Dis. 2017;70:66\u201377.","journal-title":"Blood Cells Mol Dis"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41372-018-0159-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-018-0159-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-018-0159-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:26:52Z","timestamp":1684618012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-018-0159-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["159"],"URL":"https:\/\/doi.org\/10.1038\/s41372-018-0159-y","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"type":"print","value":"0743-8346"},{"type":"electronic","value":"1476-5543"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"17 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}